Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM. DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155–66.

Article  PubMed  PubMed Central  Google Scholar 

Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367.

Article  PubMed  Google Scholar 

Bonanad C, Raposeiras-Roubin S, García-Blas S, Núñez-Gil I, Vergara-Uzcategui C, Díez-Villanueva P, Bañeras J, Badía Molins C, Aboal J, Carreras J, Bodi V, Gabaldón-Pérez A, Mateus-Porta G, Parada Barcia JA, Martínez-Sellés M, Chorro FJ. Ariza-Solé A. evaluation of the use of dual antiplatelet therapy beyond the first year after acute coronary syndrome. J Clin Med. 2022;11:1680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dégano IR, Elosua R, Marrugat J. Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049. Rev Esp Cardiol. 2013;66:472–81.

Article  PubMed  Google Scholar 

Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, Sánchez-Salado JC, Lorente V, Alegre O, Henriques JPS, D’Ascenzo F, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Cequier A. Prediction of post-discharge bleeding in elderly patients with acute coronary syndromes: insights from the BleeMACS registry. Thromb Haemost. 2018;118:929–38.

Article  PubMed  Google Scholar 

Krumholz HM, Gross CP, Peterson ED, Barron HV, Radford MJ, Parsons LS, Every NR. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J. 2003;146:839–47.

Article  PubMed  Google Scholar 

Ekerstad N, Swahn E, Janzon M, Alfredsson J, Löfmark R, Lindenberger M, Carlsson P. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation. 2011;124:2397–404.

Article  PubMed  Google Scholar 

Ruiz-Nodar JM, Esteve-Pastor MA, Rivera-Caravaca JM, Sandín M, Lozano T, Vicente-Ibarra N, Orenes-Piñero E, Macías MJ, Pernías V, Carrillo L, Candela E, Veliz A, Tello-Montoliu A, Martínez Martínez JG, Marín F. One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: results from a prospective and multicentre ACHILLES registry. Br J Clin Pharmacol. 2020;86:1052–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS. PEGASUS-TIMI 54 Steering Committee and investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372:1791–800.

Article  PubMed  Google Scholar 

D’Ascenzo F, Bertaina M, Fioravanti F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Rinaldi M, Lüscher TF. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: insights from the RENAMI registry. Eur J Prev Cardiol. 2020;27:696–705.

Article  PubMed  Google Scholar 

Sanchez F, Boasi V, Vercellino M, Tacchi C, Cannarile P, Pingelli N, Perri D, Gomez L, Cattunar S, Mascelli G. Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a “real world” STEMI population: results from the italian “CARDIO-STEMI SANREMO” registry. BMC Cardiovasc Disord. 2021;21:144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso Garcia A, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Long-term antithrombotic management patterns in asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol. 2020;43:999–1008.

Article  PubMed  PubMed Central  Google Scholar 

Bardají A, Leal M, Arrarte V, Garcia-Moll X, Pérez de Isla L, Bueno H. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.Cardiovasc Ther. 2017;35.

Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R. Patterns and impact of dual antiplatelet cessation on cardiovascular risk after percutaneous coronary intervention in patients with acute coronary syndromes. Am J Cardiol. 2019;123:709–16.

Article  PubMed  Google Scholar 

Patti G, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R. Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome. PLoS ONE. 2017;12:e0186961.

Article  PubMed  PubMed Central  Google Scholar 

Ariza-Solé A, Guerrero C, Formiga F, Aboal J, Abu-Assi E, Marín F, Bueno H, Alegre O, López-Palop R, Vidán MT, Martínez-Sellés M, Díez-Villanueva P, Vilardell P, Sionis A, Vives-Borrás M, Sanchís J, Bañeras J, Rafecas A, Llibre C, López J, González-Salvado V, Cequier À. ; LONGEVO-SCA Registry Investigators. Global geriatric assessment and in-hospital bleeding risk in elderly patients with acute coronary syndromes: Insights from the LONGEVO-SCA registry.Thromb Haemost;118:581–90.

Ariza-Solé A, Formiga F, Bardají A, Viana-Tejedor A, Alegre O, de Frutos F. Clinical characteristics and prognosis of very elderly patients with acute coronary syndrome treated with ticagrelor: insights from the LONGEVO-SCA registry. Rev Esp Cardiol. 2019;72:263–66.

Article  PubMed  Google Scholar 

2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94.

Article  Google Scholar 

Sanchis J, García Acuña JM, Raposeiras S, Barrabés JA, Cordero A, Martínez-Sellés M, Bardají A, Díez-Villanueva P, Marín F, Ruiz-Nodar JM, Vicente-Ibarra N, Alonso Salinas GL, Rigueiro P, Abu-Assi E, Formiga F, Núñez J, Núñez E. Ariza-Solé A. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome. Rev Esp Cardiol. 2021;74:765–72.

Article  PubMed  Google Scholar 

Ono M, Serruys PW, Hara H, Kawashima H, Gao C, Wang R, Takahashi K, O’Leary N, Wykrzykowska JJ, Sharif F, Piek JJ, Garg S, Mack MJ, Holmes DR, Morice MC, Head SJ, Kappetein AP, Thuijs DJFM, Noack T, Davierwala PM, Mohr FW, Cohen DJ, Onuma Y. SYNTAX extended Survival investigators. 10-year follow-up after revascularization in elderly patients with complex coronary artery disease. J Am Coll Cardiol. 2021;77:2761–73.

Article  PubMed  Google Scholar 

Morici N, De Servi S, De Luca L, Crimi G, Montalto C, De Rosa R, De Luca G, Rubboli A, Valgimigli M, Savonitto S. Management of acute coronary syndromes in older adults. Eur Heart J. 2022;43:1542–53.

Article  CAS  PubMed  Google Scholar 

García-Blas S, Bonanad C, Sanchis J. Invasive strategy in elderly patients with acute coronary syndrome in 2018: close to the truth? J Geriatr Cardiol. 2019;16:114–20.

PubMed  PubMed Central  Google Scholar 

Campo G, Maietti E, Tonet E, Biscaglia S, Ariza-Solè A, Pavasini R, Tebaldi M, Cimaglia P, Bugani G, Serenelli M, Ruggiero R, Vitali F, Formiga F, Sanchis J, Galvani M, Minarelli M, Lucchi GR, Ferrari R, Guralnik J, Volpato S. The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary dyndrome. J Gerontol A Biol Sci Med Sci. 2020;75:1113–19.

Article  CAS  PubMed  Google Scholar 

Tonet E, Campo G, Maietti E, Formiga F, Martinez-Sellés M, Pavasini R, Biscaglia S, Serenelli M, Sanchis J, Diez-Villanueva P, Bugani G, Vitali F, Ruggiero R, Cimaglia P, Bernucci D, Volpato S, Ferrari R, Ariza-Solé A. Nutritional status and all-cause mortality in older adults with acute coronary syndrome. Clin Nutr. 2020;39:1572–79.

Article  PubMed  Google Scholar 

Kwok CS, Lundberg G, Al-Faleh H, Sirker A, Van Spall HGC, Michos ED, Rashid M, Mohamed M, Bagur R, Mamas MA. Relation of frailty to outcomes in patients with acute coronary syndromes. Am J Cardiol. 2019;124:1002–11.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif